Kentucky Teachers Retirement System Invests $732,000 in Travere Therapeutics

The fund purchased 30,635 shares of the biopharmaceutical company's stock.

Published on Mar. 8, 2026

Got story updates? Submit your updates here. ›

The Teachers Retirement System of The State of Kentucky purchased a new stake in Travere Therapeutics, Inc. (NASDAQ:TVTX) in the 3rd quarter, according to its most recent disclosure with the SEC. The fund bought 30,635 shares of the company's stock, valued at approximately $732,000.

Why it matters

Travere Therapeutics is a biopharmaceutical company focused on developing therapies for rare kidney and genetic disorders, an area with limited treatment options. The investment by the Kentucky Teachers Retirement System highlights institutional interest in the company and its pipeline.

The details

The Teachers Retirement System of The State of Kentucky was not the only institutional investor to modify its holdings in Travere Therapeutics during the quarter. Emerald Advisers LLC increased its stake by 2.6%, while Essex Investment Management Co. LLC, Capital Fund Management S.A., and Squarepoint Ops LLC also bought new positions or added to existing ones.

  • The fund purchased the 30,635 shares in the 3rd quarter of 2026.

The players

Teachers Retirement System of The State of Kentucky

A pension fund that manages retirement benefits for teachers in the state of Kentucky.

Travere Therapeutics, Inc.

A biopharmaceutical company headquartered in San Diego, California, dedicated to the development and commercialization of therapies for rare kidney and genetic disorders.

Got photos? Submit your photos here. ›

The takeaway

The investment by the Kentucky Teachers Retirement System in Travere Therapeutics reflects the growing institutional interest in the company's work on rare disease treatments, an area with significant unmet medical needs.